These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39059742)

  • 1. Dynamic role of GlyT1 as glycine sink or source: Pharmacological implications for the gain control of NMDA receptors.
    Supplisson S
    Neuroscience; 2024 Jul; ():. PubMed ID: 39059742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine transporter 1 modulates GABA release from amacrine cells by controlling occupancy of coagonist binding site of NMDA receptors.
    Rozsa E; Vigh J
    J Neurophysiol; 2013 Sep; 110(6):1393-403. PubMed ID: 23803324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels.
    Martina M; Gorfinkel Y; Halman S; Lowe JA; Periyalwar P; Schmidt CJ; Bergeron R
    J Physiol; 2004 Jun; 557(Pt 2):489-500. PubMed ID: 15064326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of NMDA receptors by d-serine and glycine in mammalian spinal locomotor networks.
    Acton D; Miles GB
    J Neurophysiol; 2017 May; 117(5):1877-1893. PubMed ID: 28202572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
    Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
    Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine transport accounts for the differential role of glycine vs. D-serine at NMDA receptor coagonist sites in the salamander retina.
    Stevens ER; Gustafson EC; Miller RF
    Eur J Neurosci; 2010 Mar; 31(5):808-16. PubMed ID: 20374282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA receptor-mediated synaptic transmission in hypoglossal motorneurons.
    Lim R; Hoang P; Berger AJ
    J Neurophysiol; 2004 Oct; 92(4):2530-7. PubMed ID: 15175365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior.
    Kinney GG; Sur C; Burno M; Mallorga PJ; Williams JB; Figueroa DJ; Wittmann M; Lemaire W; Conn PJ
    J Neurosci; 2003 Aug; 23(20):7586-91. PubMed ID: 12930797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist.
    Zhang HX; Lyons-Warren A; Thio LL
    Neuropharmacology; 2009; 57(5-6):551-5. PubMed ID: 19619564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
    Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
    Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine transporter type-1 and its inhibitors.
    Harsing LG; Juranyi Z; Gacsalyi I; Tapolcsanyi P; Czompa A; Matyus P
    Curr Med Chem; 2006; 13(9):1017-44. PubMed ID: 16611082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices.
    Huang H; Barakat L; Wang D; Bordey A
    J Physiol; 2004 Nov; 560(Pt 3):721-36. PubMed ID: 15331688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo.
    Chen L; Muhlhauser M; Yang CR
    J Neurophysiol; 2003 Feb; 89(2):691-703. PubMed ID: 12574447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glycine transporter GlyT1 controls N-methyl-D-aspartic acid receptor coagonist occupancy in the mouse retina.
    Reed BT; Sullivan SJ; Tsai G; Coyle JT; Esguerra M; Miller RF
    Eur J Neurosci; 2009 Dec; 30(12):2308-17. PubMed ID: 20092573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype.
    Tsai G; Ralph-Williams RJ; Martina M; Bergeron R; Berger-Sweeney J; Dunham KS; Jiang Z; Caine SB; Coyle JT
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8485-90. PubMed ID: 15159536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake.
    Wu ZL; O'Kane TM; Connors TJ; Marino MJ; Schaffhauser H
    Brain Res; 2008 Aug; 1227():42-51. PubMed ID: 18621031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some Operational Characteristics of Glycine Release in Rat Retina: The Role of Reverse Mode Operation of Glycine Transporter Type-1 (GlyT-1) in Ischemic Conditions.
    Hanuska A; Szénási G; Albert M; Koles L; Varga A; Szabo A; Matyus P; Harsing LG
    Neurochem Res; 2016 Feb; 41(1-2):73-85. PubMed ID: 26364050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport mechanism and pharmacology of the human GlyT1.
    Wei Y; Li R; Meng Y; Hu T; Zhao J; Gao Y; Bai Q; Li N; Zhao Y
    Cell; 2024 Mar; 187(7):1719-1732.e14. PubMed ID: 38513663
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.